This company has shut down. Vaxxinity is no longer operating — its last tracked round was a Grant in 2022.
Explore the Startup GraveyardVaxxinity is a biotechnology company that enables the innovation of synthetic peptide vaccines to prevent or treat infectious diseases.
Vaxxinity has raised $9.3M in total funding. The most recent round was Grant. The last funding was announced in April 2022.
Vaxxinity's investors include Coalition for Epidemic Preparedness Innovations, White Buffalo Capital.
Vaxxinity is headquartered in Dallas, United States.
Vaxxinity is a biotechnology company that enables the innovation of synthetic peptide vaccines to prevent or treat infectious diseases.
Vaxxinity is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vaxxinity — Funding & Investors." VCBacked, April 6, 2022, https://www.vcbacked.co/company/vaxxinity. Accessed August 14, 2026.
VCBacked. (2022). Vaxxinity — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/vaxxinity
{{cite web |title=Vaxxinity — Funding & Investors |url=https://www.vcbacked.co/company/vaxxinity |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated